Lonza Group Stock - analyst consensus and technical picture on Thursday
18.06.2026 - 21:53:47 | ad-hoc-news.de
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 11:45 CET. Details in the imprint.
Lonza Group (CH0013841017) is trading on a quiet Thursday. No new ad-hoc release or major broker action is visible in the latest day-level check.
All news and analysis on Lonza stock
Track fresh coverage, company updates, and price context for Lonza Group in one place.
What the Thursday check shows
Lonza shares were last quoted at CHF 555.40 on the SIX Swiss Exchange at 11:30 CET, according to the latest quote data summarized by ad hoc news. The current setup points to a market waiting for the next company-specific trigger.
Analyst tone stays central
With no fresh company release, the focus shifts to analyst consensus and the technical picture. Lonza is still viewed as a Swiss large cap in contract development and manufacturing, a business that gives the stock a steady institutional following.
The latest ad hoc news overview notes that Lonza remains in the SMI and that the company has no officially scheduled next earnings date. That leaves valuation, sentiment, and chart levels as the main markers for the day.
What Lonza sells
Lonza provides contract development and manufacturing services for the life sciences industry. Its work ranges from drug substance and drug product production to support services for biopharma customers.
Where the stock trades today
The shares of Lonza Group (CH0013841017) trade on the SIX Swiss Exchange at CHF 555.40 as of 06/18/2026, 11:30 CET.
Key facts on Lonza stock
- Company: Lonza Group AG
- ISIN: CH0013841017
- WKN: 618132
- Ticker: LONN
- Venue: SIX Swiss Exchange
- Price (as of 06/18/2026, 11:30 CET): 555.40 CHF
- Market cap: 41,000,000,000 CHF (as of 06/18/2026)
- Sector / Industry: Health Care - Life Sciences Tools & Services / CDMO
- Index membership: SMI
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
